Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, 0.0001 par value per share
-
Shares outstanding
-
20.3M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
3.76M
-
Shares change
-
+3.76M
-
Total reported value, excl. options
-
$183M
-
Value change
-
+$183M
-
Put/Call ratio
-
0.2
-
Number of buys
-
33
-
Price
-
$48.72
Significant Holders of Vor Biopharma Inc. - Common Stock, 0.0001 par value per share (VOR) as of Q3 2025
44 filings reported holding VOR - Vor Biopharma Inc. - Common Stock, 0.0001 par value per share as of Q3 2025.
Vor Biopharma Inc. - Common Stock, 0.0001 par value per share (VOR) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.76M shares
of 20.3M outstanding shares and own 18.5% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (1.98M shares), VR ADVISER, LLC (500K shares), FCPM III SERVICES B.V. (380K shares), FMR LLC (237K shares), Ariose Capital Management Ltd (110K shares), VANGUARD GROUP INC (105K shares), UBS Group AG (75.9K shares), JOHNSON & JOHNSON (53.7K shares), TANG CAPITAL MANAGEMENT LLC (50K shares), and BlackRock, Inc. (34.5K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.